Relx (NYSE:RELX – Get Free Report) was upgraded by equities research analysts at Barclays from an “equal weight” rating to an “overweight” rating in a report issued on Friday, Marketbeat Ratings reports.
Several other equities research analysts have also issued reports on the company. Redburn Atlantic started coverage on Relx in a research report on Wednesday, January 8th. They set a “buy” rating for the company. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th.
View Our Latest Stock Analysis on RELX
Relx Stock Performance
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the company. Ameriprise Financial Inc. increased its holdings in Relx by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company’s stock worth $127,437,000 after acquiring an additional 2,208,119 shares during the last quarter. Raymond James Financial Inc. bought a new position in Relx during the fourth quarter worth about $44,516,000. Northern Trust Corp increased its stake in shares of Relx by 51.6% in the fourth quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company’s stock worth $99,542,000 after purchasing an additional 745,532 shares in the last quarter. Bank of Montreal Can raised its position in shares of Relx by 290.3% in the fourth quarter. Bank of Montreal Can now owns 886,758 shares of the technology company’s stock valued at $40,277,000 after purchasing an additional 659,547 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its stake in shares of Relx by 50.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock valued at $89,420,000 after buying an additional 658,655 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- 3 Warren Buffett Stocks to Buy Now
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- The Significance of Brokerage Rankings in Stock Selection
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.